B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008
Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000